The hESC-MSC-IMRC-CM can significantly inhibit BLM-induced pulmonary fibrosis in mice by inhibiting the production of ROS and proinflammatory cytokines by regulating Nox4/Nrf2 and Tlr4/MyD88 signaling pathway, respectively. Here, MYD88 is linked to pulmonary fibrosis.